Chemotherapy News and Research

Latest Chemotherapy News and Research

Combination of two types of radiation therapy is better for treating brain cancer

Adding stereotactic radiosurgery – which entails delivering radiation to specific points in the brain while sparing normal tissue – after whole brain radiation therapy helps certain patients with cancer that has spread to the brain live longer, says a new study by researchers at Thomas Jefferson University Hospital in Philadelphia.

25 May 2004

Results from a clinical study of CyberKnife ® radiosurgery for locally advanced pancreatic cancer

Accuray Incorporated announced today the publication of the results from a clinical study of CyberKnife ® radiosurgery for locally advanced pancreatic cancer.

25 May 2004

Baby born from 21 year old cryopreserved sperm

"We believe this is the longest period of sperm cryopreservation resulting in a live birth so far reported in the scientific literature," according to one of the authors, Dr Elizabeth Pease, Consultant in Reproductive Medicine at the Department of Reproductive Medicine at St Mary's Hospital, Manchester.

25 May 2004

X-ray beams could kick start genes into fighting cancer

X-ray beams could kick start genes into fighting cancer as an exciting new way of targeting therapy against the disease, according to new research in the Journal of Gene Medicine.

25 May 2004

Innovative new cancer drug enters the first phase of clinical trials

An innovative drug with a new mechanism of action that may be effective against a range of cancers will enter the first phase of clinical trials, it was announced today (Monday) at Cancer Research UK's Senior Researchers Meeting.

24 May 2004

Call to bring cancer genomics from the lab bench into large-scale clinical trials

Professor Patrick Johnston is one of a number of pioneering scientists exploring how intimate genetic knowledge from individual tumours could help doctors predict which treatments will benefit their patients best. Major trials of this approach – which has shown considerable success in the lab – are needed to test its full predictive potential.

24 May 2004

Patients with leukemia or lymphoma who undergo hematopoietic-cell transplantation and survive can expect full recovery to take 3-5 years

Patients with leukemia or lymphoma who undergo hematopoietic-cell transplantation (HCT) and survive can expect full recovery to take 3-5 years, according to a study published in the May 19 issue of The Journal of the American Medical Association (JAMA).

19 May 2004

$First drug approved for hormone refractory prostate cancer that has shown a survival benefit$

First drug approved for hormone refractory prostate cancer that has shown a survival benefit

The the Food and Drug Administration (FDA) approved Taxotere (docetaxel), injection in combination with prednisone ( a steroid), for the treatment of patients with advanced metastatic prostate cancer. This is the first drug approved for hormone refractory prostate cancer that has shown a survival benefit.

19 May 2004

Drug combo effective for advanced breast cancer

A pair of studies at UCLA's Jonsson Cancer Center that takes laboratory science to the patients' bedside found that combining the molecularly targeted therapy Herceptin with a specific chemotherapy combination resulted in significant tumor response rates and longer relapse-free periods in women with an aggressive form of advanced breast cancer.

19 May 2004

New book highlights pros and cons of medical use of cannabis

A new book which brings together the relevant science regarding the beneficial effects of cannabis for identified medical conditions and explains many harmful side effects has been launched at Australia's Southern Cross University today.

19 May 2004

Inactivating a protective molecule may help chemotherapy for leukemia but harm bone marrow

Inactivating a protective molecule in leukemic cells to make them more vulnerable to chemotherapy might also make healthy blood-forming cells more sensitive to the toxic effects of those same drugs.

19 May 2004

High levels of troponin I (TNI) protein in the blood helps identify possible heart damage after cancer treatment

TNI is a protein present exclusively in heart cells. The TNI blood concentration is a well-established marker of heart muscle injury that’s widely used to diagnose and treat heart attacks and other acute coronary syndromes.

18 May 2004

$1.4 million to investigate how strokes and other events that cut off blood flow to the brain disrupt the blood-brain barrier

The Cleveland Clinic has been awarded a four-year, $1.4 million grant from the National Institutes of Health to investigate how strokes and other events that cut off blood flow to the brain disrupt the blood-brain barrier. Researchers hope to use their findings to develop new methods to limit the damage caused by such events.

17 May 2004

Interventional radiologists now are able to treat using minimally invasive procedures

Interventional radiologists at Temple University Hospital now are able to treat many patients with minimally invasive procedures not available only a few years ago. “Conditions that used to require extensive surgery now take an hour or less, and patients leave with a bandaid and walk home,” says Gary Cohen, M.D., Section Chief of Interventional Radiology and Vice Chairman of Radiology. “How can you beat that?”

17 May 2004

Genetically engineered viruses may create new class of cancer therapies

A genetically engineered virus can selectively kill cancerous cells in the lung and colon while leaving healthy cells intact, according to new research published today in Cancer Research by William Wold and colleagues at Saint Louis University School of Medicine.

15 May 2004

Vitamin discovery offers clues for cancer chemotherapy

NH-Dartmouth Medical School cancer researchers, in a fusion of biochemistry and genetics, have discovered a new vitamin in a molecular pathway central to such vital processes as gene regulation, metabolism and aging. And, they found that milk contains this nutrient.

15 May 2004

Chromosome losses can signal an especially poor response to therapy

A new international study of children with a severe form of acute lymphoblastic leukemia(ALL) shows that certain chromosome losses can signal an especially poor response to therapy, but that other chromosome abnormalities have no effect on treatment survival.

13 May 2004

Phase 3 trial of Ceplene in acute myeloid leukemia meets primary trial endpoint

Maxim Pharmaceuticals has announced the results of an international Phase 3 clinical trial testing the combination of Ceplene (TM) plus interleukin-2 (IL-2) in 320 patients with acute myeloid leukemia (AML) in complete remission.

12 May 2004

Restrictions by health insurers and government to control expenses may hurt the malignant melanoma drug market

Decision Resources, Inc., a research and advisory firms focusing on pharmaceutical and health care issues, finds that restrictions by health insurers and government health authorities to control expenses may hurt the malignant melanoma drug market.

12 May 2004

Nanobodies herald a new era in cancer therapy

Cancer, along with heart and vascular disease, is the major cause of death in the Western world. The first generation of anti-cancer drugs has already saved many lives, but because these medicines are non-specific they also often have severe side effects.

12 May 2004

Chemotherapy News and Research

Latest Chemotherapy News and Research

Combination of two types of radiation therapy is better for treating brain cancer

Results from a clinical study of CyberKnife ® radiosurgery for locally advanced pancreatic cancer

Baby born from 21 year old cryopreserved sperm

X-ray beams could kick start genes into fighting cancer

Innovative new cancer drug enters the first phase of clinical trials

Call to bring cancer genomics from the lab bench into large-scale clinical trials

Patients with leukemia or lymphoma who undergo hematopoietic-cell transplantation and survive can expect full recovery to take 3-5 years

First drug approved for hormone refractory prostate cancer that has shown a survival benefit

Drug combo effective for advanced breast cancer

New book highlights pros and cons of medical use of cannabis

Inactivating a protective molecule may help chemotherapy for leukemia but harm bone marrow

High levels of troponin I (TNI) protein in the blood helps identify possible heart damage after cancer treatment

$1.4 million to investigate how strokes and other events that cut off blood flow to the brain disrupt the blood-brain barrier

Interventional radiologists now are able to treat using minimally invasive procedures

Genetically engineered viruses may create new class of cancer therapies

Vitamin discovery offers clues for cancer chemotherapy

Chromosome losses can signal an especially poor response to therapy

Phase 3 trial of Ceplene in acute myeloid leukemia meets primary trial endpoint

Restrictions by health insurers and government to control expenses may hurt the malignant melanoma drug market

Nanobodies herald a new era in cancer therapy

Cancer Research eBook

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Sensing a Healthier Future

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research eBook

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Sensing a Healthier Future

Newsletters you may be interested in